298
I. Bassanini et al. / Journal of Molecular Catalysis B: Enzymatic 134 (2016) 295–301
100:0 to 0:100), affording 7 (716 mg, 1.72 mmol, yellow solid, iso-
lated yield: 60%).
87.5, 77.33, 77.24, 77.07, 77.01, 73.9, 70.9, 70.47, 70.40, 69.26, 69.20,
61.5, 56.20, 56.17, 56.10, 51.1, 50.8.
1H NMR (400 MHz; MeOD): ı 7.04 (d, J = 2.0 Hz, 1H: H-3), 6.89
(dd, J = 8.4, 2.0 Hz, 1H: H-5), 6.76 (d, J = 8.4 Hz, 1H: H-6), 6.60 (d,
J = 16.0 Hz, 1H: Ha), 6.21 (ddd, J = 16.0, 6.8, 6.0 Hz, 1H: Hb), 4.80 (d,
J = 1.6 Hz, 1H: H-14), 4.48 (ddd, J = 12.3, 6.0, 1.6 Hz, 1H: H-7A), 4.37
(d, J = 7.6 Hz, 1H:H-8), 4.28 (ddd, J = 12.3, 6.8, 0.8 Hz, 1H: H-7B), 4.01
(dd, J = 11.2, 1.6 Hz, 1H: H-13A), 3.88 (s, 3H: = OCH3), 3.73-3.64 (m,
3H: H-13, H-16, H-18), 3.44–3.21 (m, 5H: H-9, H-10, H-11, H-12,
H-17), 1.30 (d, J = 6.4 Hz, 3H: H-19).
MS, m/z ESI = 705.3 Da [M+Na]+.
2.12. Compound 10
According to general procedure 2.9, 10 (109 mg, 0.16 mmol, oil,
isolated yield: 37%) was obtained from compound (L)-6 (380 mg,
0.89 mmol) and laccase (1.90 U).
1H NMR (400 MHz; DMSO-d6): ı 7.14 (s, 0.5H), 7.04 (s, 0.5H),
6.98–6.95 (m, 2H), 6.81–6.74 (m, 2H), 6.58 (d, J = 16.0 Hz, 1H: Ha),
6.27–6.18 (m, 1H: Hb), 5.55 (d, J = 6.0 Hz, 0.5H: Ha’A), 5.50 (d,
J = 7.3 Hz, 0·5H:Ha’B), 4.41 (dd, J = 12.8, 5.5 Hz, 1H: H-7), 4.26–4.16
(m, 3H: H-GlcanomerA, H-GlcanomerB, H-7), 4.08–3.97 (m, 2H), 3.82
(s, 1.5H: OCH3A), 3.81 (s, 1.5H: OCH3B), 3.76 (s, 1.5H: OCH3A), 3.75
(s, 1.5H: OCH3B), 3.72–3.60 (m, 4H), 3.46 (dq, J = 12.0, 6.0 Hz, 3H),
3.21–2.98 (m, 8H).
13C NMR (101 MHz; MeOD): ı 147.7, 146.3, 133.1, 128.9, 122.1,
120.0, 114.8, 109.2, 101.6, 100.9, 76.7, 75.5, 73.7, 72.6, 70.97, 70.83,
70.3, 69.5, 68.4, 54.9, 16.7.
MS, m/z ESI = 511.3 Da [M+Na]+.
2.9. Laccase-mediated dimerization. General experimental
procedure
1C NMR (101 MHz; DMSO-d6): ı 148.02, 147.97, 147.84, 147.75,
146.93, 146.80, 144.22, 144.15, 132.6, 132.33, 132.27, 132.11,
130.78, 130.70, 129.8, 129.2, 124.08, 124.06, 119.2, 118.8, 116.14,
116.05, 115.77, 115.72, 111.16, 111.07, 110.9, 103.45, 103.31, 102.4,
87.57, 87.56, 77.45, 77.39, 77.36, 77.32, 77.26, 74.00, 73.94, 70.61,
70.54, 69.26, 69.20, 61.60, 61.57, 61.54, 56.22, 56.19, 56.11, 51.1,
50.8.
To a solution of phenylpropanoid glycoside (0.05 M) in acetate
buffer (0.02 M, pH 5.0), the needed amount of a 1 mg mL−1
(4.6 U mL−1) laccase solution, prepared in the same buffer, was
added to achieve the value of 2.5 U mmolsubstrate−1. The resulting
mixture was incubated at 30 ◦C and 300 rpm and monitored by TLC
(mobile phase MeOH: chloroform: H2O; 6:4:0.5, or MeOH: AcOEt:
H2O; 6:4:0.5). Once the starting glycoside was consumed, the pH of
the medium was changed to 7.0 and the mixture was lyophilized.
The crude product was purified by flash column chromatography
(mobile phase MeOH: chloroform: H2O; 7:3:0.3 or MeOH: AcOEt:
H2O; 7:3:0.3), affording the desired dimers as a mixtures of trans-
diastereoisomers.
MS, m/z ESI = 705.3 Da [M+Na]+.
2.13. Compound 11
According to general procedure 2.9, 11 (74 mg, 0.07 mmol, oil,
isolated yield: 33%) was obtained from compound 7 (225 mg,
0.46 mmol) and laccase (1.12 U).
1H NMR (400 MHz; D2O, mixture of diastereoisomers): ı 7.01
(br s, 1H), 6.96 (dd, J = 8.5, 1.4 Hz, 1H), 6.86-6.80 (m, 2H), 6.58
(d, J = 15.8 Hz, 1H: Ha), 6.24-6.17 (m, 1H: Hb), 5.60 (d, J = 6.0 Hz,
0.5H: Ha’A), 5.55 (d, J = 6.8 Hz, 0.5H: Ha’B), 4.49–4.42 (m, 2H: H-
GlcanomerA, H-7), 4.38–4.29 (m, 2H: H-GlcanomerB, H-7), 4.08–4.01
(m, 1H), 3.96–3.91 (m, 3H), 3.89-3.83 (m, 5H), 3.80-3.76 (m, 4H),
3.73–3.56 (m, 7H), 3.53–3.23 (m, 11H), 1.25–1.15 (m, 6H).
13C NMR (101 MHz; D2O, mixture of diastereoisomers): ı 147.6,
147.2, 143.8, 133.7, 131.1, 128.4, 123.1, 119.0, 115.86, 115.78, 115.6,
110.9, 110.3, 102.9, 101.4, 100.61, 100.45, 96.1, 88.0, 75.8, 74.7, 73.2,
72.1, 70.28, 70.10, 69.6, 68.7, 66.7, 56.12, 55.97, 50.7, 48.9, 16.7.
MS, m/z ESI = 997.3 Da [M+Na]+.
2.10. Compound 8
According to general procedure 2.9, 8 (31 mg, 0.07 mmol, oil,
isolated yield: 35%) was obtained from compound (D)-5 (63 mg,
0.20 mmol) and laccase (0.32 U).
1H NMR (400 MHz; MeOD, mixture of diastereoisomers): ı
7.54 (s, 0.5H), 7.47 (s, 0.5H), 7.25–7.23 (m, 2H), 6.79–6.74 (m,
3H), 6.64 (d, J = 15.6 Hz, 1H: Ha), 6.29–6.20 (m, 1H: Hb), 5.57 (d,
J = 6.0 Hz, 0.5H: Ha’A), 5.53 (d, J = 6.4 Hz, 0.5H: Ha’B), 4.54-4.48 (m,
1H), 4.40–4.37 (m, 2H: H-anomerA+B), 4.36–4.30 (m, 1H), 4.23–4.15
(m, 1H), 3.92–3.79 (m, 3H), 3.72–3.60 (m, 4H), 3.42–3.22 (m, 14H).
13C NMR (101 MHz; MeOD, mixture of diastereoisomers): ı
181.9, 179.3, 159.6, 157.07, 156.99, 132.86, 132.80, 132.59, 132.39,
130.0, 128.3, 127.06, 126.94, 122.8, 122.4, 114.83, 114.81, 108.6,
103.0, 101.69, 101.64, 87.38, 87.22, 76.74, 76.63, 76.59, 73.7, 70.34,
70.24, 69.6, 61.4.
3. Results and discussion
The convenient use of piceid (4) as starting substrate to obtain
the enantiomeric trans -5-type dimers of resveratrol prompted
us to extend this approach to other phenolic glucosides. Specif-
ically, it was decided to study the laccase-mediated coupling of
phenylpropanoid glucosides, i.e. (D)-5 and (D)-6. To the best of our
knowledge, these compounds were never submitted to the oxida-
tive action of laccases. Moreover, the presence of a sugar moiety
the formation of pinoresinol-like structures, would have allowed
to limit the number of dimeric products obtained by radical cou-
pling (a detailed description of the dimeric products that could
coniferyl alcohol 2 was reported years ago [18]). In addition, it was
chemical outcome of the coupling reactions. In fact, at variance to
piceid 4, in these compounds glucose was linked very close to the
carbons (C-a and C-b, Scheme 2) that were going to become stere-
ocenters (C-a’ and C-b’, Scheme 2). Our hypothesis was that bulky
multichiral moiety in the vicinity of the reaction sites would induce
a discrimination among the possible diastereomeric products.
MS, m/z ESI = 645.3 [M+Na]+.
2.11. Compound 9
According to general procedure 2.9, 9 (150 mg, 0.22 mmol, oil,
isolated yield: 34%) was obtained from compound (D)-6 (470 mg,
1.4 mmol) and laccase (2.35 U).
1H NMR (400 MHz; DMSO-d6, mixture of diastereoisomers A
and B): 7.12 (s, 0.5H), 7.03 (s, 0.5H), 6.97–6.94 (m, 2H), 6.81-6.74
(m, 2H), 6.57 (d, J = 16.0 Hz, 1H: Ha), 6.26-6.17 (m, 1H: Hb), 5.55 (d,
J = 6.0 Hz, 0.5H: Ha’A), 5.50 (d, J = 7.2 Hz, 0.5H: Ha’B), 4.40 (dd, J = 12.8,
5.7 Hz, 1H: H-7), 4.27–4.15 (m, 3H: H-GlcanomerA, H-GlcanomerB, H-
7), 4.06–3.96 (m, 2H), 3.81 (s, 2H: OCH3A), 3.80 (s, 1H: OCH3B), 3.75
(s, 1H: OCH3A), 3.74 (s, 2H: OCH3B), 3.72–3.56 (m, 4H), 3.50–3.42
(m, 2H), 3.20–2.98 (m, 9H).
13C NMR (101 MHz; DMSO-d6, mixture of diastereoisomers):
ı 147.95, 147.91, 147.80, 147.72, 144.21, 144.14, 132.7, 132.34,
132.27, 132.18, 130.79, 130.71, 129.8, 129.2, 124.1, 119.1, 118.8,
116.10, 116.00, 115.7, 111.10, 111.08, 111.04, 110.85, 103.4, 102.3,